The Pelotonia Institute for Immuno-Oncology (PIIO) is a comprehensive bench-to-bedside research initiative focused on harnessing the body’s immune system to fight cancer at all levels. Established by a pledge of more than $100 million from Pelotonia, the PIIO represents Ohio State's commitment to grow the exciting area of immuno-oncology. Led by founding director Zihai Li, MD, PhD, the PIIO builds upon a rich portfolio of active investigator-initiated IO clinical trials being conducted at the OSUCCC – James. The Division of Medical Oncology, led by Christian Rolfo, MD, PhD, MBA, is a nationally recognized leader in cancer research, clinical care, and physician-scientist training within the Department of Internal Medicine at The Ohio State University College of Medicine. The Division’s mission is to revolutionize cancer care by advancing cutting-edge research across all tumor types, fostering a culture of collaboration and clinical excellence, recruiting and empowering top-tier talent and seamlessly translating discoveries from bench to bedside. The PIIO and the Division of Medical Oncology (MedOnc) invite applications for a research-track associate professor position to serve as managing director of a new Antibody Therapeutics Program. We seek an outstanding scientist with a distinguished track record of research in antibody discovery, engineering, and development with a focus on cancer immunotherapy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree